Banner

March 16, 2010

Crowdsourcing Drug Safety

iGuard Turns One

iGuard expected to draw 60,000 members in a year. Instead, it attracted 750,000. The coming shift in strategy—and genomics.

One Investor Out. Two In.

Quintiles Ownership Shifting

The world’s largest CRO is seeing a change to its investor mix.

One-on-one Attention

Quintiles Tailors Site Efforts

Sponsors are expending much effort to make clinical sites happy. In the last segment of our four-part series, Quintiles discusses its view on the topic.

Two Primary Vendors

Quintiles Embraces EDC

Has any CRO done more studies using EDC than Quintiles? In picking Phase Forward for most trials, Quintiles says that scalability and preferences at clinical sites helped guide its decision.

thumbnail
Crowdsourcing Drug Safety

iGuard Turns One

October 15, 2008

By SuzR

Hugo Stephenson is floored by the growth of iGuard, the consumer-oriented online medical monitoring service he started last year with financial support from Quintiles. iGuard turns one this month. When it was launched, Stephenson expected to have perhaps 60,000 people signed…

thumbnail
One Investor Out. Two In.

Quintiles Ownership Shifting

December 21, 2007

By SuzR

If all goes as planned, contract research organization (CRO) Quintiles Transnational will have a new mix of owners come January. On Dec. 21, the company announced that one investor is selling its ownership stake, while two others are staying around, and…

thumbnail
One-on-one Attention

Quintiles Tailors Site Efforts

November 30, 2007

By SuzR

Yes, investigator relationship management (IRM) efforts are sweeping through pharmaceutical companies’ headquarters these days, causing all manner of meetings over how to make clinical investigators happy and keep them bringing in quality data. But what of the contract research organization (CRO)?…

thumbnail
Two Primary Vendors

Quintiles Embraces EDC

May 17, 2007

By Mark Uehling

We dislike the phrase “tipping point.” It’s been overused to the point of meaninglessness. Malcolm Gladwell’s excellent book isn’t the problem. “Tipping point” should be retired, at least after we borrow its mojo ... just this once. If the story of…

thumbnail
Quintiles, Abbott Signed

Phase Forward: Steady Growth

May 10, 2007

By Mark Uehling

Once again, Phase Forward reported quarterly financial numbers of surprising strength. For its first quarter of 2007, the company logged a double-digit increase of 27 percent in revenue (to $30.1 million). Most of the firm is built around its InForm electronic…